Microbial membrane proteins and glycoproteins

Microbial membrane proteins and glycoproteins are a diverse class of molecules located on the outer surfaces of bacteria, viruses, fungi, and parasites. These proteins are essential for the survival and pathogenicity of microbes, performing critical roles such as maintaining structural integrity, transporting nutrients, and mediating adhesion to host tissues (Alberts et al., Molecular Biology of the Cell). In many pathogens, surface glycoproteins serve as the primary machinery for host cell entry; for instance, the influenza hemagglutinin and the HIV-1 gp120 protein are vital for viral attachment (V'kovski et al., 2021, Nature Reviews Microbiology). Because these proteins are often unique to the microbe or differ significantly from human homologs, they are primary targets for antimicrobial therapy and vaccine development. Examples include penicillin-binding proteins (PBPs) targeted by beta-lactam antibiotics and fungal beta-glucan synthase targeted by echinocandins (Bush & Bradford, 2016, Cold Spring Harbor Perspectives in Medicine). However, the high evolutionary pressure on these surface components frequently leads to mutations that result in drug resistance or immune escape, presenting a continuous challenge for clinical treatment (World Health Organization, 2023).

Other names

Microbial surface proteinsPathogen membrane proteinsEnvelope glycoproteinsSurface glycoproteinsMembrane-associated microbial proteins

Drugs targeting these components function through several distinct mechanisms: inhibition of enzymes essential for cell wall or membrane synthesis (e.g., beta-lactams targeting penicillin-binding proteins), direct physical disruption of the microbial membrane integrity (e.g., daptomycin or polymyxins), or competitive inhibition of viral glycoproteins to prevent attachment and entry into host cells (e.g., neuraminidase inhibitors or entry inhibitors).